Skip to Content
Merck

Fate of selected pharmaceuticals in river waters.

Environmental science and pollution research international (2012-08-02)
P Calza, C Medana, E Padovano, V Giancotti, C Minero
ABSTRACT

The aqueous environmental fate of two antibiotics, lincomycin and clarithromycin, and an antiepileptic drug, carbamazepine, was investigated by monitoring drugs decomposition and identifying intermediates in Po river water (North Italy). Initially, control experiments in the dark and under illumination were performed on river water spiked with drugs to simulate all possible transformation processes occurring in the aquatic system. Under illumination, these pharmaceuticals were degraded and transformed into numerous organic intermediate compounds. Several species were formed and characterised by analysing MS and MS(n) spectra and by comparison with parent molecule fragmentation pathways. River water was sampled at three sampling points in an urban area. The selected pharmaceuticals were detected in all samples. Eight transformation products identified in the laboratory simulation were found in natural river water from carbamazepine degradation, three from clarithromycin and two from lincomycin. Their transformation occurring in aquatic system mainly involved mono- and poly-hydroxylation followed by oxidation of the hydroxyl groups.

MATERIALS
Product Number
Brand
Product Description

Lincomycin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Lincomycin hydrochloride, BioReagent, suitable for cell culture
Sigma-Aldrich
Lincomycin hydrochloride, ≥90% (TLC)
Sigma-Aldrich
Lincomycin hydrochloride, 96.0-102.0% (HPLC)
Supelco
Lincomycin hydrochloride monohydrate, VETRANAL®, analytical standard